EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 6 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,408,000 | +1.3% | 140,393 | 0.0% | 0.03% | -21.2% |
| Q2 2022 | $1,390,000 | +5.5% | 140,393 | +4.9% | 0.03% | +32.0% |
| Q1 2022 | $1,318,000 | +29.5% | 133,849 | +28.3% | 0.02% | +19.0% |
| Q4 2021 | $1,018,000 | -0.2% | 104,307 | 0.0% | 0.02% | -67.2% |
| Q3 2021 | $1,020,000 | -0.7% | 104,307 | 0.0% | 0.06% | +166.7% |
| Q2 2021 | $1,027,000 | -0.9% | 104,307 | -0.4% | 0.02% | -40.0% |
| Q1 2021 | $1,036,000 | – | 104,707 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |